CRSP
Crispr Therapeutics AG
58.30$
+3.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.01 | 0.42 | 1.02 | 0.07 | 5.09 | 0.01 | 11.36 | 0.01 | 4.67 | 0.41 | 0.04 | |
| 0.05 | 0.43 | 3.45 | 1.74 | 2.37 | 3.15 | 4.09 | 1.26 | 1.42 | 1.64 | 1.31 | 2.59 | |
| -0.05 | -0.42 | -3.02 | -0.72 | 0.07 | 5.09 | -4.07 | 11.36 | -1.41 | 3.03 | -0.89 | -2.55 | |
| 0.05 | 0.43 | 3.45 | 1.74 | 2.37 | 3.15 | 3.36 | 5.46 | 5.94 | 4.89 | 3.80 | 2.95 | |
| 0.17 | 0.46 | 2.53 | 0.89 | 1.01 | 1.12 | 1.30 | 1.28 | 1.32 | 0.96 | 0.87 | 0.82 | |
| 0.23 | 0.89 | 5.98 | 2.64 | 3.38 | 4.27 | 1.30 | 6.71 | 7.25 | 5.84 | 4.64 | 3.77 | |
| -0.23 | -0.88 | -5.56 | -1.61 | -3.31 | 0.82 | -5.37 | 4.65 | -8.66 | -2.81 | -5.53 | -6.32 | |
| 0.00 | 0.00 | 0.66 | 0.00 | 0.00 | 0.44 | 0.10 | 0.30 | 0.60 | – | – | – | |
| -0.23 | -0.88 | -1.85 | -1.66 | -3.43 | 1.18 | -5.28 | 4.72 | -8.37 | -1.90 | -4.30 | -6.43 | |
| 0.00 | 0.00 | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 | 0.04 | 0.04 | 0.04 | |
| -0.23 | -0.88 | -1.89 | -1.71 | -3.44 | 1.17 | -5.29 | 4.70 | -8.36 | -1.94 | -4.34 | -6.47 | |
| -0.22 | -0.87 | -1.12 | -1.54 | -3.24 | 0.90 | -5.24 | 4.87 | -8.35 | -1.65 | -4.07 | -6.21 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.